Sugi, JP3397060009

Sugi reports first-quarter revenue above estimates: what it means for Sugi stock

Published on 10/07/2026 at 05:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sugi reported JPY 270.18 billion revenue in the first quarter. For Sugi stock, earnings per share were JPY 19.07 versus JPY 21.43 expected.

Sugi, JP3397060009, Illustration mit AI erstellt.
Sugi, JP3397060009, Illustration mit AI erstellt.

Sugi Holdings (JP3397060009) reported JPY 270.18 billion in revenue for the first quarter of fiscal 2027, above the JPY 267.52 billion estimate cited by Investing.com for the July 9, 2026 results. The result gives Sugi stock a concrete operating signal, while earnings per share came in below the estimate.

Revenue clears the estimate

Yahoo Finance reported first-quarter fiscal 2027 revenue of JPY 270.18 billion and earnings of JPY 6.9 billion. Revenue was 0.99 percent above the JPY 267.52 billion estimate, a modest beat that points to continued sales expansion in Sugi's Japanese drugstore business.

The same fiscal-quarter data show revenue ahead of expectations, but the earnings line was less supportive. That split makes cost control and pharmacy profitability more important than sales growth alone.

Profit growth meets a tougher comparison

According to Yahoo Finance, GAAP earnings per share were JPY 19.07 in the first quarter of fiscal 2027 versus JPY 21.43 expected, a shortfall of 11.01 percent against the estimate. The reported profit margin was 2.55 percent for that quarter.

For the fiscal year ended February 28, 2026, Sugi generated JPY 1,010.34 billion in revenue, up 15.07 percent from JPY 878.02 billion in fiscal 2025, according to Reuters. Net income rose to JPY 44.98 billion from JPY 25.69 billion, an increase of 75.10 percent, giving the latest quarter a demanding earnings comparison.

Tokyo valuation frames the stock

Sugi Holdings was last quoted at JPY 1,241.50 on the Tokyo Stock Exchange on October 7, 2026 at 11:30 a.m. JST. Its market capitalization was JPY 462.0 billion, while the 52-week range stood at JPY 1,223.00 to JPY 1,991.00 on the same date.

The quote sits JPY 18.50 above the 52-week low and JPY 749.50 below the 52-week high. That range puts the quarterly revenue beat beside a share price close to the lower end of its annual trading band.

Prior close sets the euro reference

The last Lang & Schwarz prior close was EUR 6.93 on October 5, 2026. Sugi operates drugstores in Japan and also provides dispensing pharmacy and health-support services, giving investors exposure to both retail sales and care-related operations.

The further course of trading is shown by the continuously updated real-time quote of Sugi stock.

Sugi Holdings stock facts

  • Company: Sugi Holdings Co.,Ltd.
  • ISIN: JP3397060009
  • Ticker: UGI
  • Primary exchange: Tokyo Stock Exchange
  • Prior close Lang & Schwarz (October 5, 2026): EUR 6.93
  • Market capitalization: JPY 462.0 billion (as of October 7, 2026)
  • 52-week range: JPY 1,223.00-1,991.00 (as of October 7, 2026)
  • Sector / Industry: Healthcare / Medical - Pharmaceuticals

More news and analyses on Sugi stock

Disclaimer...

en | JP3397060009 | SUGI | boerse | 70249554 | bgmi